Physician profile
Todd Parnes
NPI 1649250614
$4,658.11
in general payments reported to CMS, 2019-2025
15 companies · $591 in 2025
The $591 reported for 2025 was more than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $141 · 2021: $1,258 · 2022: $989 · 2023: $498 · 2024: $953 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,042.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,041.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $1,270.25 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,208.94 | 2021-2025 | Dupixent |
| Stryker Corporation | $1,038.24 | 2019-2023 | Audion Et Dilation System |
| Glaxosmithkline, LLC. | $308.10 | 2022-2025 | Nucala |
| Aerin Medical INC. | $308.04 | 2019-2024 | |
| Acclarent, INC | $130.12 | 2019-2022 | |
| Optinose US, INC. | $127.15 | 2019-2022 | |
| Smith+Nephew, INC. | $64.19 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $56.74 | 2019-2023 | |
| Axogen | $43.50 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $25.62 | 2025 | |
| Hologic Sales and Service, LLC | $21.43 | 2022 | |
| Medtronic USA, INC. | $19.83 | 2020 | |
| Intersect Ent, INC. | $19.12 | 2019 | |
| Davol INC. | $16.84 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Parnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.